Synergistic Effects of Sanglifehrin-Based Cyclophilin Inhibitor NV651 with Cisplatin in Hepatocellular Carcinoma

Sonia Serrano, Ramin Massoumi(Lund University), Philippe Gallay(Scripps Research Institute), Josef Mallik(Lund University), Chamseddine Kifagi, Eskil Elmér(Medicon Village), Magnus J. Hansson(Medicon Village), Michele Tavecchio(The Wistar Institute), Alvar Grönberg(NeuroVive Pharmaceutical (Sweden))
Cancers
September 20, 2022
Cited by 5


Related Papers